Safety liver profile of teriflunomide versus interferon β in multiple sclerosis: Systematic review and indirect comparison meta-analysis-Reference-Cited by-同舟云学术

Safety liver profile of teriflunomide versus interferon β in multiple sclerosis: Systematic review and indirect comparison meta-analysis

Published:2018-11 Issue: Volume:26 Page:192-200
ISSN:2211-0348
Container-title:Multiple Sclerosis and Related Disorders
language:en
Short-container-title:Multiple Sclerosis and Related Disorders

Author:

Salas Paola Andrea Ortiz^ORCID,Parra Camila Olarte,Florez Carlos Eduardo Pinzon,Goez Lina Maria,Velez-van-Meerbeke Alberto,Rodriguez Jesus Hernan

Publisher

Elsevier BV

Subject

Clinical Neurology,Neurology,General Medicine

Reference30 articles.

1. New approaches to the diagnosis, clinical course, and goals of therapy in multiple sclerosis and related disorders;Krieger;Continuum (Minneap Minn),2016

2. Disease-modifying treatments for multiple sclerosis - a review of approved medications;Torkildsen;Eur. J. Neurol.,2016

3. Optimizing the initial choice and timing of therapy in relapsing-remitting multiple sclerosis;Farber;Ther. Adv. Neurol. Disord.,2015

4. Disease modifying therapies for relapsing multiple sclerosis;Wingerchuk;BMJ,2016

5. The transition from first-line to second-line therapy in multiple sclerosis;Dörr;Curr. Treat. Options Neurol.,2015

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Overview of Differences and Similarities of Published Mixed Treatment Comparisons on Pharmaceutical Interventions for Multiple Sclerosis;Neurology and Therapy;2020-09-25

2. A comprehensive analysis of antigen-specific autoimmune liver disease related autoantibodies in patients with multiple sclerosis;Autoimmunity Highlights;2020-04-10

3. Adherence to laboratory monitoring among people taking oral drugs for multiple sclerosis: A Canadian population-based study;Multiple Sclerosis Journal;2020-03-06

4. THE FIRST DOSING OCRELIZUMAB EXPERIENCE OF A NEUROLOGY CLINIC: A RETROSPECTIVE STUDY;Archives of Neuropsychiatry;2019

5. Drugs that act on the immune system: Immunosuppressive and immunostimulatory drugs;Side Effects of Drugs Annual;2019